Literature DB >> 19915042

Expression of the Clostridium botulinum A2 neurotoxin gene cluster proteins and characterization of the A2 complex.

Guangyun Lin1, William H Tepp, Christina L Pier, Mark J Jacobson, Eric A Johnson.   

Abstract

Clostridium botulinum subtype A2 possesses a botulinum neurotoxin type A (BoNT/A) gene cluster consisting of an orfX cluster containing open reading frames (ORFs) of unknown functions. To better understand the association between the BoNT/A2 complex proteins, first, the orfX cluster proteins (ORFX1, ORFX3, P47, and the middle part of NTNH) from C. botulinum A2 strain Kyoto F and NTNH of A1 strain ATCC 3502 were expressed by using either an Escherichia coli or a C. botulinum expression system. Polyclonal antibodies against individual orfX cluster proteins were prepared by immunizing a rabbit and mice against the expressed proteins. Antibodies were then utilized as probes to determine which of the A2 orfX cluster genes were expressed in the native A2 culture. N-terminal protein sequencing was also employed to specifically detect ORFX2. Results showed that all of the neurotoxin cluster proteins, except ORFX1, were expressed in the A2 culture. A BoNT/A2 toxin complex (TC) was purified which showed that C. botulinum A2 formed a medium-size (300-kDa) TC composed of BoNT/A2 and NTNH without any of the other OrfX cluster proteins. NTNH subtype-specific immunoreactivity was also discovered, allowing for the differentiation of subtypes based on cluster proteins associated with BoNT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19915042      PMCID: PMC2798633          DOI: 10.1128/AEM.01882-09

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  33 in total

1.  Quantitative detection of gene expression and toxin complex produced by Clostridium botulinum serotype D strain 4947.

Authors:  Hirokazu Kouguchi; Tomonori Suzuki; Kimiko Hasegawa; Shingo Mutoh; Toshihiro Watanabe; Koichi Niwa; Tohru Yoneyama; Yoshinobu Katoh; Tohru Ohyama
Journal:  J Microbiol Methods       Date:  2006-05-24       Impact factor: 2.363

2.  Gene arrangement in the upstream region of Clostridium botulinum type E and Clostridium butyricum BL6340 progenitor toxin genes is different from that of other types.

Authors:  T Kubota; N Yonekura; Y Hariya; E Isogai; H Isogai; K Amano; N Fujii
Journal:  FEMS Microbiol Lett       Date:  1998-01-15       Impact factor: 2.742

3.  Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin.

Authors:  Jae-Chul Lee; Kenji Yokota; Hideyuki Arimitsu; Hyun-Jung Hwang; Yoshihiko Sakaguchi; Jinhua Cui; Kouichi Takeshi; Toshihiro Watanabe; Tohru Ohyama; Keiji Oguma
Journal:  Microbiology       Date:  2005-11       Impact factor: 2.777

4.  Organization and phylogenetic interrelationships of genes encoding components of the botulinum toxin complex in proteolytic Clostridium botulinum types A, B, and F: evidence of chimeric sequences in the gene encoding the nontoxic nonhemagglutinin component.

Authors:  A K East; M Bhandari; J M Stacey; K D Campbell; M D Collins
Journal:  Int J Syst Bacteriol       Date:  1996-10

5.  Neurotoxin gene clusters in Clostridium botulinum type A strains: sequence comparison and evolutionary implications.

Authors:  Sean S Dineen; Marite Bradshaw; Eric A Johnson
Journal:  Curr Microbiol       Date:  2003-05       Impact factor: 2.188

Review 6.  Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins.

Authors:  M D Collins; A K East
Journal:  J Appl Microbiol       Date:  1998-01       Impact factor: 3.772

7.  Conjugative transfer of the Escherichia coli-Clostridium perfringens shuttle vector pJIR1457 to Clostridium botulinum type A strains.

Authors:  M Bradshaw; M C Goodnough; E A Johnson
Journal:  Plasmid       Date:  1998-11       Impact factor: 3.466

8.  Expression and stability of the nontoxic component of the botulinum toxin complex.

Authors:  Keita Miyata; Tohru Yoneyama; Tomonori Suzuki; Hirokazu Kouguchi; Ken Inui; Koichi Niwa; Toshihiro Watanabe; Tohru Ohyama
Journal:  Biochem Biophys Res Commun       Date:  2009-04-24       Impact factor: 3.575

9.  Effects of purification on the bioavailability of botulinum neurotoxin type A.

Authors:  Luisa W Cheng; Bruce Onisko; Eric A Johnson; J Rachel Reader; Stephen M Griffey; Ann E Larson; William H Tepp; Larry H Stanker; David L Brandon; J Mark Carter
Journal:  Toxicology       Date:  2008-05-02       Impact factor: 4.221

10.  Molecular composition of Clostridium botulinum type A progenitor toxins.

Authors:  K Inoue; Y Fujinaga; T Watanabe; T Ohyama; K Takeshi; K Moriishi; H Nakajima; K Inoue; K Oguma
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

View more
  24 in total

1.  Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

Authors:  James S Henkel; William H Tepp; Amanda Przedpelski; Robert B Fritz; Eric A Johnson; Joseph T Barbieri
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

2.  Enhancing toxin-based vaccines against botulism.

Authors:  Amanda Przedpelski; William H Tepp; Madison Zuverink; Eric A Johnson; Sabine Pellet; Joseph T Barbieri
Journal:  Vaccine       Date:  2018-01-04       Impact factor: 3.641

3.  Immunoprecipitation of native botulinum neurotoxin complexes from Clostridium botulinum subtype A strains.

Authors:  Guangyun Lin; William H Tepp; Marite Bradshaw; Chase M Fredrick; Eric A Johnson
Journal:  Appl Environ Microbiol       Date:  2014-10-31       Impact factor: 4.792

4.  Botulinum neurotoxin is shielded by NTNHA in an interlocked complex.

Authors:  Shenyan Gu; Sophie Rumpel; Jie Zhou; Jasmin Strotmeier; Hans Bigalke; Kay Perry; Charles B Shoemaker; Andreas Rummel; Rongsheng Jin
Journal:  Science       Date:  2012-02-24       Impact factor: 47.728

5.  Purification and characterization of a novel subtype a3 botulinum neurotoxin.

Authors:  William H Tepp; Guangyun Lin; Eric A Johnson
Journal:  Appl Environ Microbiol       Date:  2012-02-24       Impact factor: 4.792

6.  High-resolution crystal structure of HA33 of botulinum neurotoxin type B progenitor toxin complex.

Authors:  Kwangkook Lee; Kwok-Ho Lam; Anna Magdalena Kruel; Kay Perry; Andreas Rummel; Rongsheng Jin
Journal:  Biochem Biophys Res Commun       Date:  2014-03-12       Impact factor: 3.575

7.  Comparative functional analysis of mice after local injection with botulinum neurotoxin A1, A2, A6, and B1 by catwalk analysis.

Authors:  Molly S Moritz; William H Tepp; Heather N'te Inzalaco; Eric A Johnson; Sabine Pellett
Journal:  Toxicon       Date:  2019-06-07       Impact factor: 3.033

8.  Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1.

Authors:  Christina L Pier; Chen Chen; William H Tepp; Guangyun Lin; Kim D Janda; Joseph T Barbieri; Sabine Pellett; Eric A Johnson
Journal:  FEBS Lett       Date:  2010-11-30       Impact factor: 4.124

Review 9.  Assembly and function of the botulinum neurotoxin progenitor complex.

Authors:  Shenyan Gu; Rongsheng Jin
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

10.  Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.

Authors:  Dongxia Wang; Joan Krilich; Sabine Pellett; Jakub Baudys; William H Tepp; John R Barr; Eric A Johnson; Suzanne R Kalb
Journal:  Biochim Biophys Acta       Date:  2013-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.